CRVL — CorVel Corporation
NASDAQ
Q3 2026 Earnings Call Summary
February 3, 2026
Summary of CorVel Corporation Q3 2026 Earnings Call
1. Key Financial Results and Metrics
- Revenue: For the nine months ending December 31, 2025, revenue was $710 million, up 7% from $664 million in the prior year. The December 2025 quarter revenue was $236 million, a 3% increase from $228 million in December 2024.
- Earnings Per Share (EPS): Fiscal year-to-date EPS was $1.53, a 16% increase from $1.32 year-over-year. December 2025 quarter EPS was $0.47, up 2% from $0.46 in the same quarter last year.
- Net Income: December quarter net income was $24.1 million, slightly up from $23.8 million in December 2024.
- Share Repurchases: CorVel repurchased 185,559 shares for $13.4 million during the quarter, totaling 114.9 million shares repurchased for $868 million since inception.
- Cash Flow: Fiscal year-to-date free cash flow was $90 million, with a quarter-ending cash balance of $230 million.
2. Strategic Updates and Business Highlights
- AI Integration: CorVel is leveraging AI to enhance operational efficiency, improve client outcomes, and reduce service delivery costs. Specific initiatives include automating lower-value activities and improving claims management processes.
- Market Trends: The company noted trends in the workers' compensation market, including a decrease in work-related injuries but an increase in injury severity and medical costs, which could present growth opportunities.
- Technology Acquisition: A small technology-centric acquisition in June is expected to enhance operational efficiency in health payment integrity services.
- Net Revenue Retention: The company achieved a net revenue retention rate of 100% and a 44% close rate on new business opportunities.
3. Forward Guidance and Outlook
- CorVel remains optimistic about future growth, citing strong operational momentum and a compelling technology roadmap for 2026. The company believes that its focus on product innovation and AI will position it well to capitalize on market opportunities despite current challenges.
4. Bad News, Challenges, or Points of Concern
- Revenue Growth Deceleration: The company acknowledged a deceleration in year-over-year revenue growth, which has raised concerns among analysts. CEO Michael Combs indicated that this is not indicative of a long-term trend but rather a short-term operational factor.
- Increased Effective Tax Rate: A normalization of the effective tax rate negatively impacted earnings results.
- Competitive Pressures: The company faces challenges from competitors burdened with debt, which may limit their financial agility and ability to innovate.
5. Notable Q&A Insights
- Revenue Growth Concerns: In response to questions about the deceleration in revenue growth, management emphasized that historical revenue patterns are not linear and expressed confidence in their strategic investments and market reputation to drive future growth.
- Segment Reporting: CorVel operates within a single segment, combining patient management and network solutions, and does not provide detailed breakdowns of product performance.
Overall, while CorVel Corporation reported solid financial results and strategic advancements, it faces challenges related to revenue growth deceleration and increased tax burdens that investors will need to monitor closely.
